Cancer and neoplasms

A prospective randomized, double-blind, placebo-controlled, multi-center phase IIb study to evaluate the efficacy and safety of mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant (HSCT) (MO-TRANS (PKRPCOO1))

GO TO STUDY

PREDICT – Psoriatic arthritis Recognising Early Disease Indicators Conferring Treatment response. A pilot study to identify biomarkers to predict biologic response in patients with Psoriatic Arthritis commencing a second or third biologic drug

GO TO STUDY

VIVO Biobank (VIVO Biobank)

GO TO STUDY

Producing a novel Symptom Burden Scale for people living with Idiopathic Multicentric Castleman Disease (ISBUS)

GO TO STUDY

Development Of A CT Radiomics Approach To Assess Perivascular Fat Modification And To Predict Blood Pressure Response After Renal Artery Denervation: The Molten Study

GO TO STUDY

SCN1A Horizons: A natural history study of SCN1A-related epilepsies in the United Kingdom (SCN1A Horizons)

GO TO STUDY

LUNA (CP-MGC026-01) - A Phase 1/1b, First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC026 in Participants with Advanced Solid Tumors (LUNA)

GO TO STUDY

Paediatric Intracranial Hypertension: Monitoring intracranial pressure using ophthalmological imagin (PICMO)

GO TO STUDY

Longitudinal Magnetic Resonance Imaging (MRI) Study of 11-18 Year Olds with Traumatic Brain Injury

GO TO STUDY

Cancer and neoplasms

A Phase 1/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis

GO TO STUDY